Home › Aerocrine Resumes Sales and Marketing of Niox Mino in China after Re-Registration Approval
 

Keywords :   


Aerocrine Resumes Sales and Marketing of Niox Mino in China after Re-Registration Approval

2014-12-15 11:14:35| Appliances - Topix.net

Aerocrine AB , a leader in products to monitor and manage airway inflammation associated with Asthma, announced today that its handheld airway inflammation monitoring device, NIOX MINO, has been re-registered for marketing and sales by the China Food and Drug Administration . The approval means that Aerocrine and its partners can now resume its sales and marketing activities of NIOX MINO and grow the deployed base in the Chinese market.

Tags: sales china marketing approval

Category:Consumer Goods and Services

Latest from this category

All news
22.11'Scammers sent courier to steal 4,000'
22.11Spain fines budget airlines including Ryanair 179m
22.11Formulating Biphasic and Triphasic Products
22.11Gatwick terminal evacuated due to security risk
22.1168% of US households have a smart TV, 46% have a streaming media player
22.11Reliance and Disney complete India JV transaction
22.11HbbTV Association appoints Service List Registry
22.11ocilion brings Prime Video and YouTube to its IPTV platform
Consumer Goods and Services »
23.11
23.11 WEEZER / maladroit 12\"
23.11
23.11 6'1ML REV-S
23.11speak up storys
23.11190mm LS0713FL
23.11That's Moulton
23.11SEED
More »